French Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Novacyt

Market Cap: €32.8m

Provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, France, the United States, the Asia Pacific, the Middle East, and Africa.

DBV Technologies

Market Cap: €207.5m

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products.

Aelis Farma

Market Cap: €16.7m

A clinical-stage biotechnology company, focuses on discovering and developing drug candidates for the treatment of central nervous system disorders.

Sanofi

Market Cap: €113.1b

A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.

Ipsen

Market Cap: €8.0b

Operates as a biopharmaceutical company worldwide.

Boiron

Market Cap: €427.1m

Manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally.

Virbac

Market Cap: €2.5b

Manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East.

Eurobio Scientific Société anonyme

Market Cap: €244.6m

Engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer.

MaaT Pharma

Market Cap: €95.4m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Valneva

Market Cap: €527.2m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Cellectis

Market Cap: €99.5m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates.

Sensorion

Market Cap: €62.9m

A biotechnology company, develops drug candidates for the treatment of inner ear disorders in France.

Vetoquinol

Market Cap: €866.1m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Euroapi

Market Cap: €253.5m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use.

Genfit

Market Cap: €163.0m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

genOway Société anonyme

Market Cap: €25.9m

A biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide.

OSE Immunotherapeutics

Market Cap: €127.5m

A clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally.

TME Pharma

Market Cap: €6.1m

A clinical-stage biopharmaceutical company, focuses on the development of proprietary therapeutics for the treatment of cancer in Germany.

Eurofins-Cerep

Market Cap: €103.9m

Provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally.

ABIONYX Pharma

Market Cap: €42.3m

A biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases.

Eurofins Scientific

Market Cap: €9.8b

Provides various analytical testing and laboratory services worldwide.

Valbiotis

Market Cap: €16.1m

Engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France.

Innate Pharma

Market Cap: €147.3m

Operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally.